|
103
|
347
|
8vxeA |
Structure of p38 alpha (mitogen-activated protein kinase 14) complexed with inhibitor 6 |
|
87
|
293
|
8vxfB |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 15 |
|
84
|
292
|
8vxdA |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 7 |
|
89
|
295
|
8vxfA |
Structure of casein kinase i isoform delta (ck1d) complexed with inhibitor 15 |
|
61
|
247
|
8u4wA |
The crystal structure of a helical domain deleted parp1 in complex with isoindolinone based inhibitor. |
|
42
|
116
|
8ga2A |
Bromodomain of cbp liganded with inhibitor icbp5 |
|
40
|
114
|
8g6tA |
Bromodomain of cbp liganded with inhibitor icbp2 |
|
88
|
324
|
8tjlA |
Egfr kinase in complex with pyrazolopyrimidine covalent inhibitor |
|
88
|
266
|
7ltyA |
Bruton's tyrosine kinase in complex with compound 23 |
|
251
|
871
|
7sfeA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and inhibitor gsk3830334a |
|
255
|
871
|
7sffA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and inhibitor gsk3852279b |
|
93
|
271
|
6orrA |
Co-crystal structure of human nicotinamiden-methyltransferase (nnmt) in complex with high-affinity alkynyl bisubstrate inhibitor ns1 |
|
81
|
267
|
7suhA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 15 |
|
78
|
268
|
7suiA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 22 |
|
76
|
291
|
6oqoA |
Cdk6 in complex with cpd24 n-(5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a]azepin-3-yl)pyrimidin-2-amine |
|
72
|
263
|
7sujA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 24 |
|
84
|
269
|
7sufA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 06 |
|
74
|
291
|
6oqlA |
Cdk6 in complex with cpd13 (r)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a]azepin-3-yl)-n-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine |
|
132
|
380
|
7rxxA |
Human methionine adenosyltransferase 2a bound to methylthioadenosine and two sulfate in the active site |
|
199
|
585
|
7rspA |
Structure of the vps34 kinase domain with compound 14 |
|
78
|
299
|
6oqiA |
Cdk2 in complex with cpd14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4h-pyrazolo[1,5-a]azepin-3-yl)-n-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine) |
|
134
|
381
|
7rxwA |
Human methionine adenosyltransferase 2a bound to methylthioadenosine and inhibitor imido-diphosphate (pnp) |
|
116
|
345
|
7rueA |
Dahp synthase complexed with trifluoropyruvate semicarbazone |
|
68
|
215
|
6pwzA |
Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidocytidine |
|
103
|
291
|
7r9nA |
Crystal structure of hpk1 in complex with gne1858 |
|
93
|
290
|
7r9pA |
Crystal structure of hpk1 in complex with compound 14 |
|
41
|
150
|
7l23A |
Hiv integrase core domain in complex with inhibitor 2-(5-(3-fluorophenyl)-2-(2-(thiophen-2-yl)ethynyl)-1- benzofuran-3-yl)ethanoic acid |
|
42
|
150
|
7l2yAAA |
Hiv integrase core domain in complex with inhibitor 2-(5-(3-fluorophenyl)-2-(2-(thiophen-2-yl)ethynyl)-1- benzofuran-3-yl)ethanoic acid |
|
84
|
269
|
7sugA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 09 |
|
90
|
265
|
7ltzA |
Bruton's tyrosine kinase in complex with compound 51 |
|
87
|
300
|
7wctA |
Crystal structure of fgfr4 kinase domain with 7v |
|
89
|
300
|
7wcxA |
Crystal structure of fgfr4(v550m) kinase domain with 7v |
|
208
|
586
|
7rsjA |
Structure of the vps34 kinase domain with compound 14 |
|
115
|
346
|
7rudA |
Dahp synthase complex with trifluoropyruvate oxime |
|
182
|
698
|
7t39A |
Co-crystal structure of human prmt9 in complex with mt221 inhibitor |
|
203
|
585
|
7rsvA |
Structure of the vps34 kinase domain with compound 5 |
|
234
|
871
|
7sfgA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and cofactor sam |
|
244
|
872
|
7sfdA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and inhibitor gsk3543105a |
|
253
|
871
|
7sfcA |
Human dnmt1(729-1600) bound to zebularine-containing 12mer dsdna and inhibitor gsk3735967a |
|
71
|
308
|
7runA |
Crystal structure of phosphorylated ret tyrosine kinase domain complexed with a pyrrolo[2,3-d]pyrimidine inhibitor. |
|
86
|
301
|
7mfcA |
Crystal structure of csf1r in complex with vimseltinib |
|
98
|
291
|
7r9tA |
Crystal structure of hpk1 in complex with compound 17 |
|
83
|
305
|
7rj7A |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand 2-(1-amino-3-methylbutyl)-6- (pyridin-4-yl)quinoline-4-carbonitrile |
|
80
|
276
|
6n0qA |
Braf in complex with n-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-5-yl)phenyl)-3-(trifluoromethyl)benzamide. |
|
83
|
288
|
7r9lA |
Crystal structure of hpk1 in complex with compound 2 |
|
90
|
300
|
7wcwA |
Crystal structure of fgfr4(v550l) kinase domain with 7v |
|
89
|
297
|
7rj8A |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand (2r)-2-amino-n-[3-(difluorom ethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide |
|
106
|
332
|
6vxrA |
Structure of maternal embryonic leucine zipper kinase bound to ldsm276 |
|
67
|
225
|
7n8eA |
Pptt pap(coa) 9056 complex |
|
63
|
225
|
7n8lA |
Pptt pap(coa) 9016 complex |
